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Summary
Objectives: We aimed to determine nasopharyngeal colonization rates and antibiotic resistance
patterns of Streptococcus pneumoniae isolated from Guatemalan children, and to determine risk
factors for colonization and antibiotic nonsusceptibility.
Methods: Isolates were obtained from children aged 5 to 60 months attending public and private
outpatient clinics and daycare centers during August 2001—June 2002 and outpatient clinics
during November 2005—February 2006 in Guatemala City. Minimal inhibitory concentrations of
penicillin, trimethoprim—sulfamethoxazole (TMS), cefotaxime, and erythromycin were deter-
mined using the E-test.
Results: The overall nasopharyngeal colonization rate for S. pneumoniaewas 59.1%. From 2001/2
to 2005/6 TMS nonsusceptibility increased from 42.4% to 60.8% ( p < 0.05) in public clinics and
from 51.4% to 84.0% ( p = 0.009) in private clinics, and penicillin nonsusceptibility increased from
1.5% to 33.3% in public clinics (p < 0.001). Reported antibiotic use was not strictly associated
with nonsusceptibility to that same antibiotic. Resistance to three or four antibiotics increased in
public clinics from 2001/2 (0%) to 2005/6 (10.7%; p < 0.001). Risk factors for nasopharyngeal
colonization with penicillin- or TMS-nonsusceptible S. pneumoniae were low family income,
daycare center attendance, and recent penicillin use.* Corresponding author. Tel.: +502 2364 0492; fax: +502 2369 7539.
E-mail address: edueger@jhsph.edu (E.L. Dueger).
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Conclusions: Increasing antibiotic nonsusceptibility rates in nasopharyngeal S. pneumoniae isolates
from Guatemalan children reflect worldwide trends. Policies encouraging more judicious use of TMS
should be considered.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Antibiotic-resistant Streptococcus pneumoniae has emerged
as a problem in many countries,1,2 necessitating change to
more costly antibiotics — antibiotics that developing countries
often cannot afford.3 Although some infections with pneumo-
cocci of intermediate resistance (minimal inhibitory concen-
tration (MIC) 0.1—1.0 mg/ml) can be treatedwith high doses of
penicillin, bacteria with a higher degree of resistance
(MIC > 1.0 mg/ml) are often resistant to other antibiotics,
including cephalosporins.4 There is limited information on
the distribution of antibiotic-resistant S. pneumoniae in the
developing world, although the prevalence of S. pneumoniae
of decreased susceptibility is increasing.5—9
In most developing countries, the availability and use of
antibiotics differ dramatically among different socioeco-
nomic strata. Children from higher socioeconomic groups
are often prescribed broad-spectrum antibiotics, while chil-
dren in lower economic classes generally have access to only
a small number of inexpensive antimicrobials. The ‘no-con-
trol’ policy of antibiotic prescriptions in most developing
countries has accelerated the emergence of multiple-resis-
tant diarrheal pathogens and could be a catalyst for the
emergence of antibiotic-resistant S. pneumoniae.
Nasopharyngeal (NP) colonization with S. pneumoniae
precedes invasive infection, and the nasopharynx is likely
the site where selection and transmission of resistant strains
occurs.10,11 Although a number of studies have examined
serotype distributions and antibiotic susceptibility patterns
of invasive S. pneumoniae isolates in Latin America,8,12—15
few investigations of NP isolates have been conducted in this
region. The aims of the current study were to determine
nasopharyngeal colonization rates and antibiotic resistance
patterns of S. pneumoniae isolated from Guatemalan chil-
dren, and to determine risk factors for colonization and
antibiotic nonsusceptibility.
Materials and methods
Study population
This study was approved by the institutional review boards at
the Johns Hopkins Bloomberg School of Public Health and the
Universidad del Valle. Nasopharyngeal isolates were obtained
in two studies. Children who had not received antibiotics in
the previous 2 weeks were eligible. Children aged 5 to 60
months (study NP2001/2) were enrolled between August
2001 and June 2002 at a public hospital outpatient clinic,
a public daycare center, four private daycare centers, and
two private pediatric clinics. A second group of children
(study NP2005/6) aged 24 months was enrolled between
November 2005 and February 2006 at the same public hospi-
tal outpatient clinic and three private pediatric clinics.
Administration of the pneumococcal 7-valent conjugatevaccine (Prevenar; Wyeth Pharmaceuticals, Philadelphia,
PA, USA) at 2, 4, and 6 months of age has been available
in the private pediatric clinics since 2003, but is rarely used
due to cost. This vaccine has not yet been introduced in the
public sector. Data were not collected on vaccination history.
Written informed consent was obtained from a parent or
guardian prior to enrollment. A standardized questionnaire
including demographics, potential risk factors, and antibiotic
use (as reported by respondent) was administered to the
parent or guardian of each child.
Nasopharyngeal sampling
Nasopharyngeal secretions were obtained by inserting a
sterile calcium alginate tipped swab (Calgiswab Type 1;
Spectrum Laboratories, Houston, TX, USA) into the nasophar-
ynx to a depth of 3—4 cm. Swabs were streaked immediately
onto blood agar plates (trypticase soy base with 5% sheep
blood) supplemented with gentamicin (Becton Dickinson,
Cockeysville, MD, USA), refrigerated, and transported to
the laboratory within 4 hours of procurement. Streaked
plates were incubated at 34—35 8C in 5% CO2 atmosphere
for 24—48 hours. Colonies of alpha-hemolysis were evaluated
for bacterial Gram stain and morphology and optochin disk
susceptibility. All isolates were stored in duplicate, frozen in
glycerol citrate at70 8C. Serotyping was later performed by
latex agglutination using standard sera (Statens Serum Insti-
tut, Copenhagen, Denmark), and confirmed by the Quellung
reaction.
Optochin and oxacillin disk screening
Presumptive identification of S. pneumoniae was made by
susceptibility to optochin. Plates were incubated in a CO2
atmosphere for 18—24 hours. Alpha-hemolytic strains with a
zone of inhibition of growth 15 mm in diameter were
considered pneumococci. No alpha-hemolytic strains with
zones of inhibition ranging between 9 and 13 mmwere found.
All S. pneumoniae isolates were inoculated into trypticase
soy broth (0.5 McFarland standard) and plated on Mueller—
Hinton blood agar plates with a 1-mg oxacillin disk, and
incubated at 37 8C for 18—24 hours. Isolates exhibiting
<20-mm-diameter zones around the oxacillin disk were con-
sidered potentially penicillin nonsusceptible and underwent
further susceptibility confirmation. Isolates with a 20-mm
zone of inhibition were considered to be susceptible to
penicillin.
Minimal inhibitory concentration testing
MICs of selected antibiotics (penicillin, cefotaxime, erythro-
mycin, and trimethoprim—sulfamethoxazole (TMS)) were
determined using the E-test. The purity of isolates was
assured by streaking frozen isolates for single colonies on
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at 34—35 8C in 5% CO2 atmosphere for 24—48 hours. A final
bacterial density of McFarland 108 was inoculated into Muel-
ler—Hinton 5% sheep blood agar where E-test strips were
placed and incubated for 20 hours at 34—35 8C in a 5% CO2
atmosphere. S. pneumoniae isolates were defined as suscep-
tible, intermediate, or resistant according to E-test manu-
facturer specifications (Table 1) and National Committee on
Clinical Laboratory Standards (NCCLS) criteria. Intermediate
and resistant isolates were combined (nonsusceptible group)
for analyses. Due to limited funds, a stratified random selec-
tion of 150 of the 478 isolates was selected for serotyping in
the NP2001/2 study. Serotypes/groups were determined for
76 isolates from the NP2005/6 study; four isolates could not
be recovered from frozen samples for serotyping.
Data analysis
Statistical analyses were performed with the Statistical
Package for Social Sciences (SPSS-PC version 10; Chicago,
IL, USA). Proportions were compared using 2-tailed Chi-
square test with Yates’ correction or Fisher’s exact tests.
The Student t-test was used to compare group means. Non-
parametric variables were compared using the Mann—Whit-
ney test. Univariate and multivariate logistic regression
models were used to identify risk factors for NP carriage
of S. pneumoniae and to compare risk factors between
children with isolates susceptible to penicillin and TMS and
those with isolates nonsusceptible to these antibiotics. TheTable 1 E-test interpretations
Antibiotic Susceptible
Penicillin 0.06 mg/ml
Cefotaxime 1 mg/ml
Erythromycin 0.5 mg/ml
Trimethoprim—sulfamethoxazole 0.5 mg/ml
Table 2 Population characteristics by site
2001/2 Study
Daycare centers
Public
(n = 190)
Private
(n = 177)
Male (%) 94 (50) 91 (51)
Mean age, months (SE) 40 (1) 38 (1)
Attend daycare (%) 190 (100) 177 (100)
Family income <$400/month (%) 189 (99) 17 (10)a
Woodstove (vs. gas/electric) (%) 11 (6) 0 (0)a
Number/bedroom 2 (%) 147 (77) 39 (22)a
Antibiotics in previous 3 months (%)
None 86 (45) 77 (44)
Penicillin 84 (44) 72 (41)
Trimethoprim—sulfamethoxazole 5 (3) 9 (5)
Cephalosporins 15 (8) 24 (14)
Macrolides 4 (2) 22 (12)a
ap < 0.001 for public vs. private; bsample size is 65 due to missing dat
private; ep = 0.007 for public vs. private.independent variables for each analysis were individual
exposure to antibiotics, age, gender, number of people per
bedroom, household income, tobacco exposure, use of a
wood stove in the home, previous episodes of illnesses,
and daycare center attendance. For all statistical analyses,
a significance level of p < 0.05 was used to reject the null
hypothesis.
Results
A total of 751 children were enrolled in the NP2001/2 study:
199 (26.5%) from a public hospital outpatient clinic, 190
(25.3%) from a public daycare center, 177 (23.6%) from four
private daycare centers, and 185 (24.6%) from two private
pediatric clinics. A total of 200 children were enrolled in the
NP2005/6 study: 100 (50.0%) from the public hospital out-
patient clinic and 100 (50.0%) from three private pediatric
clinics. Children enrolled from public daycare centers and
clinics were more likely than those enrolled from private
daycare centers and clinics to belong to households with low
family income, to have wood stoves in the home, and to have
2 people per bedroom (Table 2). When compared to chil-
dren from higher-income households, children in lower-
income households were significantly more likely to have
received penicillin or TMS and less likely to have received
cephalosporins or macrolides (Table 3).
Overall, 562 (59.1%) children were colonized with S.
pneumoniae; colonization rates were consistently lower in
private settings than in public settings. Colonization rates inIntermediate Resistant
0.12—1 mg/ml 2 mg/ml
2 mg/ml 4 mg/ml
1 mg/ml 2 mg/ml
12 mg/ml 4 mg/ml
2005/6 Study
Clinics Clinics
Public
(n = 199)
Private
(n = 185)
Public
(n = 100)
Private
(n = 100)
115 (58) 102 (55) 48 (48) 54 (54)
26 (1) 28 (1) 13.4 (0.51) 14.5 (0.60)
9 (5) 74 (40) 6 (6.0) 17 (17)
198 (99) 14 (8)a 96 (96) 15 (15)a
56 (28) 2 (1)a 19 (19) 0 (0)a
172 (86) 47 (25)a 37 (57)b 22 (24)a,c
96 (48) 97 (52) 33 (33) 63 (63)a
83 (42) 49 (26)d 48 (48) 14 (14)a
10 (5) 10 (5) 24 (24) 2 (2)a
11 (6) 25 (14)e 9 (9) 7 (7)
9 (5) 25 (14)d 7 (7) 11 (11)
a; c sample size is 92 due to missing data; dp = 0.001 for public vs.
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Table 4 Nasopharyngeal carriage rates by study site
Study N Carriage of Streptococcus
pneumonia, n (%)
2001/2
Daycare centers
Privatea 177 113 (63.8)
Publica 190 160 (84.2)
Clinics
Privateb,d 185 85 (45.9)
Publicb 199 120 (60.3)
2005/6e
Privatec,d 100 28 (28.0)
Public c 100 56 (56.0)
Total, all studies 951 562 (59.1)
ap < 0.001; bp = 0.004; cp < 0.001; dp < 0.003; e2005/6 data
were collected from clinics only.
Table 3 Antibiotic use in the previous 3 months by family
incomea
Family income p-Value
<$400/month,
n (%)
>$400/month,
n (%)
Penicillin 228 (43.1) 122 (28.9) <0.001
Trimethoprim—
sulfamethoxazole
41 (7.8) 19 (4.5) 0.04
Cephalosporins 41 (7.8) 50 (11.8) 0.035
Macrolides 23 (4.3) 55 (13) <0.0001
a Antibiotic use data were collected by parent/guardian report.private clinics decreased from 2001/2 to 2005/6 (Table 4).
Colonization rates during 2001/2, for which data collection
spanned 11 months (August—June), did not show seasonal
differences (62.0% for the rainy season vs. 68.3% for the dry
season).
E-test results were available for 554 of the 562 isolates. Of
these, a total of 347 (62.6%), 149 (26.9%), and 155 (28.0%)Figure 1 Proportion of Streptococcus pneumoniae isolates from c
cefotaxime, erythromycin, penicillin, and trimethoprim—sulfametho
PEN, penicillin; TMS, trimethoprim—sulfamethoxazole. ap < 0.00
gp < 0.001; hp < 0.001; ip < 0.001; jp = 0.004; kp = 0.025.isolates were nonsusceptible to TMS, penicillin, and erythro-
mycin, respectively. Among these nonsusceptible isolates,
51.0%, 41.6%, and 99.4% were fully resistant to TMS, peni-
cillin, and erythromycin, respectively. All 18 cefotaxime-
nonsusceptible isolates were of intermediate resistance.
During the 2001/2 period, a greater percentage of isolates
were nonsusceptible to TMS during the rainy season (36.8%)
than the dry season (22.8%; p = 0.004), and more isolates
were nonsusceptible to penicillin, erythromycin and TMS
during the dry season (29.4%) than the rainy season
(12.3%; p < 0.001). However, when the data were stratified
by public versus private setting, these differences were no
longer significant.
Nonsusceptibility of isolates to TMS increased from
2001/2 to 2005/6 in both public and private clinics
(Figure 1). The percentage of isolates nonsusceptible to
penicillin increased from 2001/2 to 2005/6 in the public
clinics. Combined data from the public and private clinics
showed increases in the percentage of isolates that were
nonsusceptible to TMS (45.5% in 2001/2 vs. 68.4% in 2005/
6; p = 0.0025) and penicillin (11.9% in 2001/2 vs. 35.5% in
2005/6; p < 0.001). This shift reflected a significant
increase in the percentage of isolates with intermediate
resistance to TMS (28.2% in 2001/2 to 46.1% in 2005/6) and
penicillin (13.4% in 2001/2 to 30.3% in 2005/6). When data
from both time periods were combined, a greater percen-
tage of isolates from private clinics than from public clinics
were nonsusceptible to penicillin (35% vs. 15.4%, respec-
tively; p = 0.003) and erythromycin (38.3% vs. 12.8%,
respectively; p < 0.001).
The percentage of isolates nonsusceptible to each of the
four antibiotics was higher among S. pneumoniae isolates
obtained in 2001/2 from children in private clinics than
isolates obtained in public settings (Figure 1). TMS nonsus-
ceptibility was higher in isolates from children attending
public daycare centers than for isolates from children in
private daycare centers. When the data from private and
public settings were combined, higher percentages of iso-
lates from daycare centers than clinics were nonsusceptible
to TMS (71.1% vs. 49.3%, respectively; p < 0.001), penicillin
(33.0% vs. 15.6%, respectively; p < 0.001), and erythromycin
(34.4% vs. 20.5%, respectively; p < 0.001).hildren attending daycare centers and clinics, nonsusceptible to
xazole; 2001/2 and 2005/6. CEF, cefotaxime; ERY, erythromycin;
1; bp < 0.05; cp = 0.009; dp = 0.028; ep = 0.003; fp < 0.001;
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Table 5 Multivariate logistic regression analysis of risk factors for colonization with Streptococcus pneumoniae, penicill onsusceptible S. pneumoniae, and trimethoprim—
sulfamethoxazole-nonsusceptible S. pneumoniae
S. pneumoniae a Penicillin-nonsusceptible S. pneumoniae b Trimethoprim—sulfamethoxazole-
nonsusceptible S. pneumoniaeb
Uncolonized Colonized OR (95% CI) p-Value P-S P-N OR (95% CI) p-V e TMS-S TMS-N OR (95% CI) p-Value
Age in months 0.98 (0.97—0.99) 0.001 0.98 (0.96—0.99) <0 1 - -
Income <$400/month 171/389
(44.0)
358/562
(63.7)
1.7 (1.3—2.4) 0.001 293/405
(72.3)
58/149
(38.9)
0.33 (0.17—0.60) <0 1 140/207
(67.6)
212/347
(61.1)
0.68 (0.49—0.95) 0.022
Daycare
Private pre-school 108/389
(27.8)
159/562
(28.3)
2.6 (1.7—4.0) <0.001 86/405
(21.2)
74/149
(49.7)
2.4 (1.3—4.4) 0 4 55/207
(26.6)
104/347
(30.0)
1.7 (1.2—2.4) 0.002
Public daycare center 34/389
(8.7)
170/562
(30.2)
5.4 (3.3—8.9) <0.001 134/405
(33.1)
36/149
(24.2)
3.1 (1.6—6.0) 0 1 42/207
(20.3)
128/347
(36.9)
3.8 (2.4—6.0) <0.001
Penicillin in
last 3 months
138/405
(34.1)
65/149
(43.6)
1.6 (1.1—2.5) <0 1 66/207
(31.9)
137/347
(39.5)
1.5 (1.1—2.2) 0.025
Number/bedroom 2 152/361
(42.1)
312/547
(57.0)
- - 261/393
(66.4)
49/147
(33.3)
0.42 (0.26—0.68) <0 1
Wood stove
(vs. gas or electric)
24/389
(6.2)
64/562
(11.4)
2.0 (1.2—3.5) 0.012
TMS, trimethoprim—sulfamethoxazole; P-S, penicillin-susceptible; P-N, penicillin-nonsusceptible; TMS-S, trimethoprim—sulfameth zole-susceptible; TMS-N, trimethoprim—sulfamethox-
azole-nonsusceptible.
a Sex, smoker in the house, prior antibiotic use, and prior illness were also included in initial model but were not significant.
b Sex, smoker in the house, prior illness, trimethoprim—sulfamethoxazole use, erythromycin use, and cefotaxime use were also uded in initial model but were not significant.in-n
alu
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Figure 2 Percentage of Streptococcus pneumoniae isolates nonsusceptible to various antibiotics by serotype/group. CEF, cefotax-
ime; ERY, erythromycin; PEN, penicillin; TMS, trimethoprim—sulfamethoxazole.Overall, 113 of 554 (20.4%) isolates were nonsusceptible
to multiple (three or four) antibiotics; multidrug nonsuscept-
ibility rates were not different for the two time periods
(20.9% in 2001/2 vs. 17.1% in 2005/6). Among isolates
obtained in 2001/2, multidrug nonsusceptibility rates were
higher in private than public daycare centers (41.6% vs.
15.6%, respectively; p < 0.001) and private versus public
clinics (32.9% vs. 0%, respectively; p < 0.001). Nonsuscept-
ibility to multiple antibiotics increased in public clinics from
2001/2 (0%) to 2005/6 (10.7%; p < 0.001).
After adjustment for other factors, each one-month
increase in age was associated with a 2% decrease in risk
of S. pneumoniae colonization (Table 5). Other factors sig-
nificantly associated with colonization were family income
<$400 per month, daycare center attendance (public or
private), and presence of a wood stove in the home. Among
children colonized with S. pneumoniae, risk factors for car-
riage of penicillin-nonsusceptible isolates were young age,
daycare center attendance (public or private), and penicillin
use in the previous 3 months. Family income <$400 per
month and 2 people per bedroom were protective against
colonization with a penicillin-nonsusceptible isolate. Risk
factors for carriage of TMS-nonsusceptible isolates were day-
care center attendance (public or private) and penicillin use
in the previous 3 months; income <$400 per month was
protective.
The five most common serotypes/groups isolated were 19,
23, 6, 18, and 8. Less than 25% of serotypes/groups 19, 6, and
18 were susceptible to all four antibiotics tested. Nonsus-
ceptibility to all four antibiotics tested was present in 2—8%
of isolates in the three serotypes/groups most commonly
isolated (19, 23, and 6; Figure 2). There were no significant
differences in distribution of serotypes/groups or in distribu-
tion of antibiotic nonsusceptibility patterns between the
time periods.Discussion
More thanonehalf ofGuatemalanchildren aged5 to60months
were colonized with S. pneumoniae, within the wide range of
colonization rates (14% to61%) reported forchildren less than5
years of age in Latin America.5,16—19 The increasing nonsus-
ceptibility of isolates to TMS and penicillin across time has
been noted in other countries.1,3,5,20—27 The risk factors for NP
colonizationandcolonizationwithpenicillin-nonsusceptibleS.
pneumoniae including age, daycare center attendance,
crowding, and income are consistent with findings in other
countries.5,26,28—38 Use of a wood stove in the home as the
primary method of cooking was also associated with increased
rates of NP S. pneumoniae colonization. Other studies have
shown associations between childhood respiratory tract infec-
tion rates and wood stove use in the home.39—42
Antibiotic nonsusceptibility rates in S. pneumoniae iso-
lates are commonly thought to be associated with antibiotic
exposure.43—48 In our study, according to antibiotic use
reported by parents, exposures to penicillin and TMS were
higher in public settings, and cephalosporin and macrolide
exposures were higher in private settings. In private settings
in 2001/2, nonsusceptibility to penicillin, erythromycin, and
cefotaxime was higher than in public settings. Interestingly,
although penicillin use was higher among children from
public settings, penicillin resistance was higher among chil-
dren attending private clinics. Also in 2001/2, nonsuscept-
ibility to TMS, penicillin, and erythromycin was higher in
daycare centers than clinics, although only reported peni-
cillin use was higher in private daycares. Furthermore, after
adjustment for factors such as income, daycare center atten-
dance, and age, recent penicillin use was a risk factor for
colonization with penicillin- or TMS-nonsusceptible isolates,
but TMS use was not found to be a significant risk factor for
carriage of nonsusceptible isolates. Thus, our data suggest
Nasopharyngeal S. pneumoniae isolates, Guatemala 295that antibiotic nonsusceptibility of S. pneumoniae isolates is
not strictly associated with antibiotic use. Antibiotic use data
reported by parents could be inaccurate.49,50 Furthermore,
antibiotic nonsusceptibility is not always a clear one-to-one
relationship between antibiotic exposure and resistance to
that same antibiotic, but is likely complicated by bacterial
acquisition of plasmids that often confer resistance to multi-
ple antibiotics.51—53 Finally, macrolide use in the private
clinics may have contributed to penicillin resistance despite
low levels of reported penicillin use.54—56
S. pneumoniae serotypes/groups 19, 23, and 6 were the
most commonly isolated, and a small percentage of each
group was nonsusceptible to all four antibiotics tested. If
these same resistance patterns were found in isolates asso-
ciated with invasive disease, treatment options would
potentially be limited. The three most commonly isolated
serotypes/groups are included in the PCV-7 vaccine, but this
vaccine is not used routinely in Guatemala. Efforts to
increase control, regulation, and more judicious use of
antibiotics are likely to aid in reducing or reversing the rise
in antibiotic-resistant S. pneumoniae,45,47,57,58 and are
needed in Guatemala. Efforts should be made to address
the problem of over-the-counter antibiotic sales in Guate-
mala, especially the sale of single doses rather than full
courses. The control of antibiotic overuse and misuse in
Guatemala will require programs aimed at prescribers, dis-
pensers, and consumers.
The World Health Organization recommends TMS use as
part of its Integrated Management of Childhood Illness pro-
gram aimed at improving prevention and management of
major childhood illnesses in developing countries. Our data
along with data from other countries worldwide3,5,21—23,25,27
demonstrating increases in TMS resistance of S. pneumoniae,
indicate that policies encouraging the use of TMS may have
adverse consequences. In the face of rising resistance to TMS,
revised recommendations encouraging more judicious use of
TMS should be considered.
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